Literature DB >> 19223010

Noradrenergic neurons in the locus coeruleus contribute to neuropathic pain.

J J Brightwell1, B K Taylor.   

Abstract

Current theories of neuropathic hypersensitivity include an imbalance of supraspinal inhibition and facilitation. Our overall hypothesis is that the locus coeruleus (LC), classically interpreted as a source of pain inhibition, may paradoxically result in facilitation after tibial and common peroneal nerve transection (spared sural nerve injury--SNI). We first tested the hypothesis that non-noxious tactile hind paw stimulation of the spared sural innervation territory increases neuronal activity in the LC in male rats. We observed a bilateral increase in the stimulus-evoked expression of transcription factors Fos and phosphorylated CREB (pCREB) in LC after SNI but not sham surgery; these markers of neuronal activity correlated with the intensity of tactile allodynia. We next tested the hypothesis that noradrenergic neurons contribute to the development of neuropathic pain. To selectively destroy these neurons, we delivered antidopamine-beta-hydroxylase saporin (anti-DbetaH-saporin) into the i.c.v. space 2 weeks before SNI. We found that anti-DbetaH-saporin, but not an IgG-saporin control, reduced behavioral signs of tactile allodynia, mechanical hyperalgesia, and cold allodynia from 3 to 28 days. after SNI. Our final experiment tested the hypothesis that the LC contributes to the maintenance of neuropathic pain. We performed SNI, waited 2 weeks for maximal allodynia and hyperalgesia to develop, and then administered the local anesthetic lidocaine (4%) directly into the LC parenchyma. Lidocaine reduced all behavioral signs of neuropathic pain in a reversible manner, suggesting that the LC contributes to pain facilitation. We conclude that, in addition to its well-known inhibition of acute and inflammatory pain, the LC facilitates the development and maintenance of neuropathic pain in the SNI model. Further studies are needed to determine the facilitatory pathways emanating from the LC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223010      PMCID: PMC2677992          DOI: 10.1016/j.neuroscience.2009.02.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  72 in total

1.  A method of reversible inactivation of small regions of brain tissue.

Authors:  J G Malpeli; P H Schiller
Journal:  J Neurosci Methods       Date:  1979-08       Impact factor: 2.390

2.  Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain.

Authors:  Bradley K Taylor; Sarang S Abhyankar; Ngoc-Tram T Vo; Christopher L Kriedt; Sajay B Churi; Janice H Urban
Journal:  Pain       Date:  2007-02-02       Impact factor: 6.961

3.  Alterations in nociception following lesions of the A5 catecholamine nucleus.

Authors:  J Sagen; H K Proudfit
Journal:  Brain Res       Date:  1986-04-02       Impact factor: 3.252

4.  Ethical guidelines for investigations of experimental pain in conscious animals.

Authors:  Manfred Zimmermann
Journal:  Pain       Date:  1983-06       Impact factor: 6.961

5.  The locus coeruleus in the rat: an immunohistochemical delineation.

Authors:  R Grzanna; M E Molliver
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

6.  Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry.

Authors:  K N Westlund; J D Coulter
Journal:  Brain Res       Date:  1980-12       Impact factor: 3.252

Review 7.  The challenge of chronic pain.

Authors:  Janean E Holden; Julie A Pizzi
Journal:  Adv Drug Deliv Rev       Date:  2003-08-28       Impact factor: 15.470

8.  Influence of peripheral nerve injury on response properties of locus coeruleus neurons and coeruleospinal antinociception in the rat.

Authors:  H Viisanen; A Pertovaara
Journal:  Neuroscience       Date:  2007-04-19       Impact factor: 3.590

9.  A quantitative and morphological study of projection neurons in lamina I of the rat lumbar spinal cord.

Authors:  R C Spike; Z Puskár; D Andrew; A J Todd
Journal:  Eur J Neurosci       Date:  2003-11       Impact factor: 3.386

10.  Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Authors:  Stephan Brecht; Christine Courtecuisse; Catherine Debieuvre; Jens Croenlein; Durisala Desaiah; Joel Raskin; Claude Petit; Koen Demyttenaere
Journal:  J Clin Psychiatry       Date:  2007-11       Impact factor: 4.384

View more
  44 in total

1.  Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.

Authors:  Ji-Young V Kim; Dipti V Tillu; Tammie L Quinn; Galo L Mejia; Adia Shy; Marina N K Asiedu; Elaine Murad; Alan P Schumann; Stacie K Totsch; Robert E Sorge; Patrick W Mantyh; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

2.  Brainstem Pain-Control Circuitry Connectivity in Chronic Neuropathic Pain.

Authors:  Emily P Mills; Flavia Di Pietro; Zeynab Alshelh; Chris C Peck; Greg M Murray; E Russell Vickers; Luke A Henderson
Journal:  J Neurosci       Date:  2017-11-24       Impact factor: 6.167

3.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

Review 4.  The noradrenergic locus coeruleus as a chronic pain generator.

Authors:  Bradley K Taylor; Karin N Westlund
Journal:  J Neurosci Res       Date:  2016-09-29       Impact factor: 4.164

5.  The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain.

Authors:  Cristina Alba-Delgado; Gisela Borges; Pilar Sánchez-Blázquez; Jorge E Ortega; Igor Horrillo; Juan A Mico; J Javier Meana; Fani Neto; Esther Berrocoso
Journal:  Psychopharmacology (Berl)       Date:  2011-10-29       Impact factor: 4.530

6.  Effects of Mitochondrial Transplantation on Bioenergetics, Cellular Incorporation, and Functional Recovery after Spinal Cord Injury.

Authors:  Jenna L Gollihue; Samir P Patel; Khalid C Eldahan; David H Cox; Renee R Donahue; Bradley K Taylor; Patrick G Sullivan; Alexander G Rabchevsky
Journal:  J Neurotrauma       Date:  2018-04-30       Impact factor: 5.269

7.  Activation of NK₁ receptors in the locus coeruleus induces analgesia through noradrenergic-mediated descending inhibition in a rat model of neuropathic pain.

Authors:  Y Muto; A Sakai; A Sakamoto; H Suzuki
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  GABA-A receptor activity in the noradrenergic locus coeruleus drives trigeminal neuropathic pain in the rat; contribution of NAα1 receptors in the medial prefrontal cortex.

Authors:  R Kaushal; B K Taylor; A B Jamal; L Zhang; F Ma; R Donahue; K N Westlund
Journal:  Neuroscience       Date:  2016-08-09       Impact factor: 3.590

9.  Ferulic acid increases pain threshold and ameliorates depression-like behaviors in reserpine-treated mice: behavioral and neurobiological analyses.

Authors:  Ying Xu; Lu Zhang; Tuo Shao; Lina Ruan; Lin Wang; Jiao Sun; Jianxin Li; Xinbo Zhu; James M O'Donnell; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2013-04-14       Impact factor: 3.584

Review 10.  Spinal inhibitory neurotransmission in neuropathic pain.

Authors:  Bradley K Taylor
Journal:  Curr Pain Headache Rep       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.